Fisher & Paykel Healthcare
(ASX) FPH
Fisher & Paykel Healthcare Financials at a Glance
Market Cap
$18.75B
Revenue (TTM)
$4.26B
Net Income (TTM)
$766.98M
EPS (TTM)
$0.67
P/E Ratio
47.05
Dividend
$0.46
Beta (Volatility)
-0.06 (Low)
Dividend
$0.46
Beta (Volatility)
-0.06 (Low)
Price
$31.70
Volume
61,894
Open
$31.69
Price
$31.70
Volume
61,894
Open
$31.69
Previous Close
$32.11
Daily Range
$31.52 - $32.18
52-Week Range
$29.58 - $35.28
Dividend
$0.46
Beta (Volatility)
-0.06 (Low)
Price
$31.70
Volume
61,894
Open
$31.69
Previous Close
$32.11
Daily Range
$31.52 - $32.18
52-Week Range
$29.58 - $35.28
FPH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Fisher & Paykel Healthcare
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
7,535
CEO
Lewis George Gradon
Website
www.fphcare.comHeadquarters
Auckland, 2013, NZ
FPH Financials
Key Financial Metrics (TTM)
Gross Margin
64%
Operating Margin
27%
Net Income Margin
20%
Return on Equity
23%
Return on Capital
26%
Return on Assets
16%
Earnings Yield
2.13%
Dividend Yield
0.01%
Payout Ratio
57.35%
Stock Overview
Market Cap
$18.75B
Shares Outstanding
587.29M
Volume
61.89K
Short Interest
0.00%
Avg. Volume
484.42K
Financials (TTM)
Gross Profit
$530.20M
Operating Income
$371.00M
EBITDA
$654.30M
Operating Cash Flow
$548.60M
Capital Expenditure
$103.00M
Free Cash Flow
$445.60M
Cash & ST Invst.
$264.50M
Total Debt
$153.30M
Fisher & Paykel Healthcare Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.09B
+35.9%
Gross Profit
$692.17M
+42.4%
Gross Margin
63.39%
N/A
Market Cap
$18.75B
N/A
Market Cap/Employee
$2.69M
N/A
Employees
6,978
N/A
Net Income
$211.28M
+96.9%
EBITDA
$361.26M
+82.1%
Quarterly Fundamentals
Net Cash
$150.57M
+168.7%
Accounts Receivable
$328.73M
+51.2%
Inventory
$334.18M
-0.5%
Long Term Debt
$62.09M
-79.3%
Short Term Debt
$84.91M
+262.8%
Return on Assets
15.97%
N/A
Return on Invested Capital
26.29%
N/A
Free Cash Flow
$192.24M
+279.0%
Operating Cash Flow
$243.82M
+55.8%